An overview of the rare parotid gland cancer

Author:

Ho Kimberley,Lin Helen,Ann David K,Chu Peiguo G,Yen Yun

Abstract

Abstract Cancer of the parotid gland is relatively rare, but carries poor prognosis owing to its prevailing distant metastases. In addition to the disease's basic epidemiology and pathology, we review some current discoveries of its tumorigenesis molecular mechanism. Based on published salivary gland cancer clinical trial data, non-surgical antitumor efficacies amongst a range of chemotherapy, radiation, and concurrent therapy regimens are compared. We also present the current development status of novel radiation therapy and targeted therapeutics, focusing on intensity-modulated radiation therapy (IMRT), and epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) blockages, which are showing promise for improving parotid gland cancer management.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Otorhinolaryngology

Reference45 articles.

1. Gray H: Anatomy of the Human Body. Splanchnology, Section 2a. The Mouth. 2000, Philadelphia: Lea & Febiger, 1918; Bartleby.com, Chapter 11: Last accessed 26th July 2011, [http://www.bartleby.com/107/illus1024.html]

2. Horner MJ, Ries LAG, Krapcho M, (eds), et al: SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD. 2009, Last accessed 26th July 2011, [http://seer.cancer.gov/csr/1975_2006/index.html]

3. Spitz MR, Sider JG, Newell GR, Batsakis JG: Incidence of salivary gland cancer in the United States relative to ultraviolet radiation exposure. Head Neck Surg. 1988, 10: 205-308.

4. Surveillance, Epidemiology, and End Results (SEER) Program http://www.seer.cancer.gov SEER*Stat Database: Incidence - SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2010 Sub (2000-2008), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission. http://seer.cancer.gov/canques/incidence.html, http://canques.seer.cancer.gov/cgi-bin/cq_submit?dir=seer2008&db=6&rpt=TAB&sel=^0^4^0^0^^0&y=Sex^1,2&z=Statistic%20type^1,2,3&dec=2,2,2&template=null Last accessed 26th July 2011

5. Salivary Gland Cancer Detailed Guide. Learn About Cancer from the American Cancer Society. Last accessed 26th July 2011, [http://www.cancer.org/Cancer/SalivaryGlandCancer/DetailedGuide/salivary-gland-cancer-what-is-key-statistics]

Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3